Bayer Halts Drug Trial of Lung Cancer Treatment

by Medindia Content Team on  February 19, 2008 at 12:42 PM Drug News   - G J E 4
German drug group Bayer said Monday that it had halted trials of its leading cancer treatment Nexavar for one of the main forms of lung cancer.
Bayer Halts Drug Trial of Lung Cancer Treatment
Bayer Halts Drug Trial of Lung Cancer Treatment

Bayer said Phase III trials in patients with non-small cell lung cancer (NSCLC) had been stopped because Nexavar, already used to treat liver and some kidney cancers, "would not meet its primary end-point of improved overall survival."

Nexavar is one of the group's best selling treatments, while NSCLC is the most common form of lung cancer.

"While we are disappointed at this outcome ... we will continue to investigate its potential across a wide variety of tumors," Bayer said in a statement.

Shares in the German drug company fell 1.28 percent to 83.46 euros while the overall stockmarket rose nearly two percent.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

View All